ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

FRLN Freeline Therapeutics Holdings PLC

6.48
0.00 (0.00%)
May 02 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Freeline Therapeutics Holdings PLC FRLN NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 6.48 20:00:00
Open Price Low Price High Price Close Price Prev Close
6.48 6.48
more quote information »

Recent News

Date Time Source Heading
4/24/202416:00GLOBEFreeline to Present New Data on its Gaucher and Parkinson’s..
2/26/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
2/22/202416:38EDGAR2Form S-8 POS - Securities to be offered to employees in..
2/22/202416:28EDGAR2Form POS AM - Post-Effective amendments for registration..
2/20/202415:22EDGAR2Form SC 13E3/A - Going private transaction by certain..
2/20/202407:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/20/202407:00GLOBEAcquisition of Freeline by Syncona Becomes Effective
2/12/202416:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/12/202412:00GLOBEFreeline Shareholders Approve Acquisition by Syncona
1/18/202416:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/17/202416:17EDGAR2Form SC 13E3/A - Going private transaction by certain..
12/08/202317:21EDGAR2Form SC 13E3 - Going private transaction by certain issuers
12/01/202308:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/22/202309:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/22/202307:30GLOBESyncona to Acquire Freeline Therapeutics
10/25/202306:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/25/202302:01GLOBEFreeline Presents Positive New Data from Phase 1/2 GALILEO-1..
10/18/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/16/202307:00GLOBEFreeline to Present New Clinical Data for FLT201 in Gaucher..
10/06/202316:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/04/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/04/202307:00GLOBEFreeline Reports Positive Initial Clinical Data from First..
8/15/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/15/202307:00GLOBEFreeline Reports Second Quarter 2023 Financial Results and..
8/08/202307:30GLOBEFreeline Therapeutics to Host Second Quarter 2023 Financial..
7/31/202307:30GLOBEFreeline to Participate in Upcoming Investor Conferences
7/25/202307:30GLOBEFreeline to Host Virtual KOL Event on its Gene Therapy..
6/26/202307:30GLOBEFreeline Announces First Patient Dosed with Its Novel Gene..
6/02/202308:00GLOBEFreeline to Present at 2023 Jefferies Healthcare Conference
5/30/202307:30GLOBEFreeline Reports First Quarter 2023 Financial Results and..
5/22/202308:00GLOBEFreeline Granted ILAP Designation in United Kingdom by MHRA..
5/12/202308:05GLOBEFreeline Completes ADS Ratio Change

Your Recent History

Delayed Upgrade Clock